Location History:
- Tokyo, JP (2014)
- Shinjuku-ku, JP (2021)
Company Filing History:
2 out of 158 
1 out of 210 
Years Active: 2014-2021
Title: Yoichi Nakao: Innovator in Medical Composition and Antiprotozoal Remedies
Introduction
Yoichi Nakao is a distinguished inventor based in Shinjuku-ku, Japan. He has made significant contributions to the fields of medical compositions and antiprotozoal remedies. With a total of 2 patents, Nakao's work focuses on innovative solutions for combating serious health issues.
Latest Patents
Nakao's latest patents include a marine organism-derived extract, compound, and medical composition that suppresses the niche formation of leukemic stem cells. This invention utilizes the cobblestone area (CA) formation inhibitory activity of human leukemic stem cell-like cells as an indicator. A fraction with this activity has been extracted from the fat-soluble fraction of Porifera, leading to the identification of a novel Stelliferin compound. This compound has been shown to significantly suppress the niche formation of leukemic stem cell-like cells derived from human chronic myelogenous leukemia (CML), enhancing the effects of antitumor agents.
Another notable patent is an antiprotozoal compound derived from coelenterata. This invention aims to develop a remedy with a novel mechanism of action. The compound is represented by a specific chemical formula, which includes various components that contribute to its effectiveness as a pharmaceutical agent.
Career Highlights
Throughout his career, Nakao has worked with reputable institutions, including Waseda University and Yakult Honsha Co., Ltd. His research has led to advancements in medical treatments and has garnered attention in the scientific community.
Collaborations
Nakao has collaborated with notable colleagues such as Shigetaka Asano and Daisuke Arai. These partnerships have played a crucial role in the development of his innovative patents.
Conclusion
Yoichi Nakao's contributions to medical compositions and antiprotozoal remedies highlight his commitment to advancing healthcare solutions. His innovative patents reflect a deep understanding of complex biological mechanisms and a dedication to improving patient outcomes.